June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Histological Difference between Myopic Parapapillary Beta Zone versus Glaucomatous Parapapillary Beta Zone
Author Affiliations & Notes
  • Songhomitra Panda-Jonas
    Privatpraxis Prof Jonas und Dr Panda-Jonas, Heidelberg, Germany
  • Rahul A Jonas
    Klinikum der Universitat zu Koln Zentrum fur Augenheilkunde, Koln, Nordrhein-Westfalen, Germany
  • Jost B. Jonas
    Ophthalmology, Universitat Heidelberg, Heidelberg, Baden-Württemberg, Germany
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
  • Footnotes
    Commercial Relationships   Songhomitra Panda-Jonas European patent EP 3 271 392, JP 2021-119187, and US 2021 0340237 A1: „Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia, Code P (Patent); Rahul Jonas European patent EP 3 271 392, JP 2021-119187, and US 2021 0340237 A1: „Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia, Code P (Patent); Jost Jonas European patent EP 3 271 392, JP 2021-119187, and US 2021 0340237 A1: „Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia, Code P (Patent)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2032. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Songhomitra Panda-Jonas, Rahul A Jonas, Jost B. Jonas; Histological Difference between Myopic Parapapillary Beta Zone versus Glaucomatous Parapapillary Beta Zone. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2032.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To examine the histological characteristics of myopic parapapillary beta zone and of macular retinal pigment epithelium (RPE) defects in myopic macular patchy atrophies, and their differentiation from glaucomatous parapapillary beta zone.

Methods : Using light microscopy, we histomorphometrically examined human enucleated eyes.

Results : The histomorphometric study included 17 eyes (17 patients; mean age: 70.5±13.5 years; axial length:26.6±3.6mm;range:22.0-32.0mm), differentiated into a group of glaucomatous, non-highly myopic eyes (axial length <26mm;n=8) and highly myopic eyes (axial length ≥26mm;n=9). The prevalence (8/8 versus 1/9;P<0.001) and length (21±62µm versus 367±163µm;P<0.001) of parapapillary alpha zone was lower, prevalence of parapapillary drusen of the retinal pigment epithelium (4/8 versus 0/9;P<0.01) was higher, and Bruchs membrane (BM) was thicker (5.1±3.9µm versus 2.7±1.2µm;P=0.07) in the glaucomatous group versus the highly myopic group. BM thickness did not differ significantly in the region peripheral to alpha zone and beta zone between both groups (2.82±0.45µm versus 2.55±0.45µm;P=0.33), as did the RPE cell density outside of alpha/beta zone (11.8±7.7 cells/unit versus 16.5±5.5 cells/unit;P=0.28). RPE density was significantly lower in alpha zone than in the region peripheral to alpha zone (8.0±8.4 cells/unit versus 14.7±6.6 cells/unit;P=0.008).

Conclusions : In the parapapillary region, glaucomatous beta zone differs from myopic beta zone by the presence and size of a surrounding alpha zone and a thicker BM in beta zone, while both types of beta zone did not differ significantly in the RPE cell density outside of alpha/beta zone. These findings may be of interest to discuss the etiology of glaucomatous versus myopia parapapillary beta zone.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×